Lapathoside A
CAS No. 373646-49-2
Lapathoside A ( —— )
产品货号. M32666 CAS No. 373646-49-2
Lapathoside A and vanicoside B, inhibited the promotion stages on two-stage carcinogenesis induced by TPA.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥4617 | 有现货 |
|
| 50MG | 获取报价 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Lapathoside A
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Lapathoside A and vanicoside B, inhibited the promotion stages on two-stage carcinogenesis induced by TPA.
-
产品描述Lapathoside A and vanicoside B, inhibited the promotion stages on two-stage carcinogenesis induced by TPA.
-
体外实验——
-
体内实验——
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number373646-49-2
-
分子量986.9
-
分子式C50H50O21
-
纯度>98% (HPLC)
-
溶解度DMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
3-Sulfopropanoic aci...
3-Sulfopropanoic acid, a major metabolite of treprostinil and its prodrug ALZ-801, is an endogenous molecule present in the cerebrospinal fluid (CSF) of AD patients that inhibits the formation of Aβ42 oligomers.
-
[Thr6]-Bradykinin
[Thr6]-Bradykinin
-
Tacitin
苯佐克胺盐酸盐具有镇静和抗焦虑的特性。苯佐克胺盐酸盐阻断中枢突触后血清素受体。
021-51111890
购物车()
sales@molnova.cn

